OGDH and ovarian cancer: Recently, we demonstrated that the inhibition of the TCA cycle utilizing the inhibitor CP1–613, which targets TCA cycle enzymes pyruvate dehydrogenase (PDHA1) and 2-oxoglutarate dehydrogenase (OGDH), significantly decreased the growth of xenografts derived from resistant ovarian cancer cells23.